Literature DB >> 9663144

What it takes to control tuberculosis.

C R Horsburgh.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9663144      PMCID： PMC1508283          DOI： 10.2105/ajph.88.7.1015

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  18 in total

1.  Patterns of tuberculosis transmission in Central Los Angeles.

Authors:  P F Barnes; Z Yang; S Preston-Martin; J M Pogoda; B E Jones; M Otaya; K D Eisenach; L Knowles; S Harvey; M D Cave
Journal:  JAMA       Date:  1997-10-08       Impact factor: 56.272

2.  Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary?

Authors:  R Bayer; C Stayton; M Desvarieux; C Healton; S Landesman; W Y Tsai
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

3.  Distinct trends in tuberculosis morbidity among foreign-born and US-born persons in New Jersey, 1986 through 1995.

Authors:  Z Liu; K L Shilkret; J Tranotti; C G Freund; L Finelli
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

4.  Making DOTS succeed. Directly Observed Treatment, Short Course.

Authors:  J M Grange; A Zumla
Journal:  Lancet       Date:  1997-07-19       Impact factor: 79.321

5.  Trends in drug-resistant tuberculosis in the United States, 1993-1996.

Authors:  M Moore; I M Onorato; E McCray; K G Castro
Journal:  JAMA       Date:  1997-09-10       Impact factor: 56.272

6.  Community isoniazid prophylaxis program in an underdeveloped area of Alaska.

Authors:  M L Hanson; G W Comstock; C E Haley
Journal:  Public Health Rep       Date:  1967-12       Impact factor: 2.792

7.  Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis.

Authors:  R D Moore; C P Chaulk; R Griffiths; S Cavalcante; R E Chaisson
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

Review 8.  Nosocomial tuberculosis: new progress in control and prevention.

Authors:  J E McGowan
Journal:  Clin Infect Dis       Date:  1995-09       Impact factor: 9.079

9.  A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

Authors:  F M Gordin; J P Matts; C Miller; L S Brown; R Hafner; S L John; M Klein; A Vaughn; C L Besch; G Perez; S Szabo; W El-Sadr
Journal:  N Engl J Med       Date:  1997-07-31       Impact factor: 91.245

10.  The fall after the rise: Tuberculosis in the United States, 1991 through 1994.

Authors:  M T McKenna; E McCray; J L Jones; I M Onorato; K G Castro
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308
View more
  3 in total

Review 1.  Management of children with prolonged fever of unknown origin and difficulties in the management of fever of unknown origin in children in developing countries.

Authors:  G O Akpede; G I Akenzua
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Patient satisfaction with care at directly observed therapy programs for tuberculosis in New York City.

Authors:  H Davidson; M Smirnoff; S J Klein; E Burdick
Journal:  Am J Public Health       Date:  1999-10       Impact factor: 9.308

3.  Increasing Latino adolescents' adherence to treatment for latent tuberculosis infection: a controlled trial.

Authors:  Melbourne F Hovell; Carol L Sipan; Elaine J Blumberg; C Richard Hofstetter; Donald Slymen; Lawrence Friedman; Kathleen Moser; Norma J Kelley; Alicia Y Vera
Journal:  Am J Public Health       Date:  2003-11       Impact factor: 9.308
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.